NEWS AND ANNOUNCEMENTS

A major shift in 2026 is the use of Polygenic Risk Scores (PRS) for preventative health. PRS combines thousands of small genetic variants to calculate an individual's overall risk for a condition.

• Cardiovascular Risk: The NHS is trialing PRS alongside traditional risk factors (blood pressure, cholesterol) to identify "high-risk" individuals in their 30s who may benefit from early statin therapy or lifestyle interventions.

• Cancer Screening: Women with a high PRS for breast cancer, even without a BRCA mutation, are being offered more frequent or earlier screenings.

Spain is a European leader in Neuromodulation for Failed Back Surgery Syndrome (FBSS) and Complex Regional Pain Syndrome (CRPS).

• SCS (Spinal Cord Stimulation): Both high-frequency (HF10) and tonic stimulation are utilized in specialized Spanish centers.

• DRG (Dorsal Root Ganglion) Stimulation: Specifically indicated for localized neuropathic pain and radicular pain that is unresponsive to traditional SCS. The 2026 guidelines emphasize a "graded approach," starting with the least invasive interventions before moving to permanent neurostimulation implants.

A significant shift in the 2026 Spanish market is the move toward Desktop 3D Printing within the clinic.

• Biocompatible Resins: Suppliers now provide specialized resins for printing indirect bonding trays, retainers, and surgical guides.

• Workflow Efficiency: By 3D printing models in-house, Spanish clinics reduce their reliance on external labs, shortening the time from consultation to treatment start to as little as 48 hours.

Livestock vaccines in 2026 are the primary defense against economic devastation. The UK dairy industry heavily utilizes vaccines for Bovine Respiratory Disease (BRD) and BVD (Bovine Viral Diarrhoea).

• Bluetongue Virus (BTV): Due to warmer UK summers, the midge-borne Bluetongue virus has become a persistent threat. In 2026, the government has subsidized BTV vaccination programs in "high-risk" coastal counties to prevent mass culls and protect the domestic lamb and beef supply.

• Economic Impact: Research shows that every £1 spent on livestock vaccines saves the UK farming economy an estimated £7.40 in lost productivity and veterinary intervention costs.